Grande E - Search Results

1

Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation.

Molina-Cerrillo J, Alonso-Gordoa T, Carrato A, Grande E. Molina-Cerrillo J, et al. Among authors: grande e. Oncotarget. 2022 Nov 17;13:1245. doi: 10.18632/oncotarget.28312. Oncotarget. 2022. PMID: 36395352 Free PMC article. No abstract available.

2

Advances in the therapy of gastroenteropancreatic-neuroendocrine tumours (GEP-NETs).

Grande E, Díez JJ, Pachón V, Carrato A. Grande E, et al. Clin Transl Oncol. 2010 Jul;12(7):481-92. doi: 10.1007/s12094-010-0541-5. Clin Transl Oncol. 2010. PMID: 20615825 Review.

3

Response by Choi criteria to sunitinib plus octreotide LAR in a functional heavily pretreated advanced pancreatic neuroendocrine tumor.

Grande E, José Díez J, Pachón V, Angeles Vaz M, Longo F, Guillén C, García de Paredes ML, Carrato A. Grande E, et al. Anticancer Drugs. 2011 Jun;22(5):477-9. doi: 10.1097/CAD.0b013e328344484b. Anticancer Drugs. 2011. PMID: 21346550

4

Complete response to sunitinib in a patient with relapsed irresectable renal cell carcinoma.

Vaz MA, Pachón V, Grande E, Ferreiro R, Carrato A. Vaz MA, et al. Among authors: grande e. Anticancer Drugs. 2011 Sep;22(8):817-21. doi: 10.1097/CAD.0b013e3283437ff9. Anticancer Drugs. 2011. PMID: 21566523

5

New targeted approaches against the ubiquitin-proteasome system in gastrointestinal malignancies.

Grande E, Earl J, Fuentes R, Carrato A. Grande E, et al. Expert Rev Anticancer Ther. 2012 Apr;12(4):457-67. doi: 10.1586/era.12.26. Expert Rev Anticancer Ther. 2012. PMID: 22500683 Review.

6

A significant response to sunitinib in a patient with anaplastic thyroid carcinoma.

Grande E, Capdevila J, Díez JJ, Longo F, Carrato A. Grande E, et al. J Res Med Sci. 2013 Jul;18(7):623-5. J Res Med Sci. 2013. PMID: 24516498 Free PMC article.

7

What could Nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer?

Capdevila J, Carrato A, Tabernero J, Grande E. Capdevila J, et al. Among authors: grande e. Crit Rev Oncol Hematol. 2014 Nov;92(2):83-106. doi: 10.1016/j.critrevonc.2014.05.004. Epub 2014 May 14. Crit Rev Oncol Hematol. 2014. PMID: 24924525 Review.

8

GEP-NETs update: Biotherapy for neuroendocrine tumours.

Alonso-Gordoa T, Capdevila J, Grande E. Alonso-Gordoa T, et al. Among authors: grande e. Eur J Endocrinol. 2015 Jan;172(1):R31-46. doi: 10.1530/EJE-14-0354. Eur J Endocrinol. 2015. PMID: 25430657 Review.

9

Advances in thyroid cancer treatment: latest evidence and clinical potential.

Alonso-Gordoa T, Díez JJ, Durán M, Grande E. Alonso-Gordoa T, et al. Among authors: grande e. Ther Adv Med Oncol. 2015 Jan;7(1):22-38. doi: 10.1177/1758834014551936. Ther Adv Med Oncol. 2015. PMID: 25553081 Free PMC article. Review.

10

Primary Sarcomatoid Tumor of the Bladder: A Different Entity but the Same Approach?

Molina-Cerrillo J, Martínez-Sáez O, Alonso-Gordoa T, Tirado-Zambrano P, Delgado-Vargas B, Earl J, Grande E. Molina-Cerrillo J, et al. Among authors: grande e. Clin Genitourin Cancer. 2015 Dec;13(6):493-8. doi: 10.1016/j.clgc.2015.05.001. Epub 2015 May 13. Clin Genitourin Cancer. 2015. PMID: 26027772 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters